Licensing activities are excellent opportunities for companies that want to expand their portfolio or gain return on investment in a relatively short period.

Out-licensing is a new phenomenon for the Indian pharma. The licensing strategy can make a critical drug globally accessible, and technology collaboration can enable an experimental drug for early entry. We also do product development and offer early entry to the Emerging & Expansion markets.

We cater to diverse portfolios across USA, EU, Japan & ANZ.

Your Benefit:

  • Local expertise in most regulated and emerging markets.
  • Insights into the needs of our customer and access to decision makers.
  • Ability to handle the particularities with local know-how.
  • Track record of successful license deals.
  • Customized services - Regulatory Affairs, Intellectual Property, Quality & Supply Chain Management.